Hepatitis C Articles & Analysis
12 articles found
Such advancements could lead to potent treatments for chronic viral infections such as hepatitis C and HIV, which have long evaded complete eradication. Immunomodulatory Therapies The concept of harnessing the body’s immune response against viral infections has gained traction over the years. ...
Biomedical liquid waste originating from healthcare facilities, laboratories, and research centers often contains infectious materials that, when discharged without proper treatment, can contribute to the spread of communicable diseases through public sewers. These diseases can affect individuals coming into contact with contaminated water sources ...
For instance, interferon-alpha is used to treat hepatitis C infection, while interleukin-2 is used to treat certain types of cancer. ...
Another method that helps promote the native conformation is adding extra auxiliary sequences at the sides of epitopes, such as linking the yeast protein GCN4 to the C and N termini of short peptides, promoting the formation of an α-helical structure in epitopes.Pan HLA-DR-binding epitope (PADRE) is an auxiliary peptide used to stimulate antibody-mediated B cell responses and has ...
The rapid accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling pathway represents one of those targets for broad-spectrum antiviral drug development as it is exploited by many viruses during their replication cycle, e.g., coronaviruses, Ebola virus, hepatitis C virus, respiratory syncytial ...
This product, which was marketed under the brand name Immulin, was originally used to treat viral hepatitis B and C. Not only was this treatment highly convenient to administer – since it enabled treatment without the need for injections – it showed a very safe side effect profile with high patient tolerability and compliance. ...
The Risks There are more than 20 blood borne pathogens that can be transmitted by needlestick injuries. These include:?Hepatitis B; Hepatitis C; Human immunodeficiency virus (HIV) ; Ebola; Syphilis, Herpes, and Brucellosis. ...
In May 2011, the FDA approved the marketing of Merck's hepatitis C treatment, Victrelis, also known as Boceprevir. The structural formula is as follows. ...
Clinical studies have documented numerous effective benefits and support for people facing a variety of health challenges, including: a) Asthma b) Atherosclerosis c) Autoimmune disease d) Bronchitis e) Cancer f) Chronic obstructive pulmonary disease ... ...
The occurrence of liver cancer is a very complex process, controlled by a variety of risk factors, including hepatitis B virus and hepatitis C virus infection, alcohol abuse, non-alcoholic fatty liver, genetic mutations, and long-term exposure to aflatoxin. ...
The FDA inspection of the ReGen product manufacturer found problems with its process, including that the facility had not screened the umbilical cord blood donors for diseases such as HIV, hepatitis B, and hepatitis C. Patients reported symptoms of pain, swelling, and chills within a few days of receiving the stem cell product, which was later ...
Here we show that SRSF3 is decreased in human liver samples with nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), or cirrhosis that was associated with alterations in RNA splicing of known SRSF3 target genes. Hepatic SRSF3 expression was similarly decreased and RNA splicing dysregulated in mouse models of NAFLD and NASH. ...